Anzeige
Mehr »
Montag, 06.10.2025 - Börsentäglich über 12.000 News
Das Paradox-Becken beweist seine Stärke - und American Critical Minerals sitzt direkt darauf
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41083 | ISIN: US68620A3023 | Ticker-Symbol: 4OR
Lang & Schwarz
06.10.25 | 11:54
1,220 Euro
-100,00 % -1,220
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
VIVOSIM LABS INC Chart 1 Jahr
5-Tage-Chart
VIVOSIM LABS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,2101,23011:54

Aktuelle News zur VIVOSIM LABS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
28.08.VivoSim Labs, INC. - S-8, Securities to be offered to employees in employee benefit plans20
14.08.VivoSim Labs names Tony Lialin as chief commercial officer9
14.08.VivoSim Labs, Inc.: VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer439SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim Labs"), a pharmaceutical and biotechnology services company that is focused on providing testing...
► Artikel lesen
14.08.VivoSim Labs, INC. - 8-K, Current Report3
12.08.VivoSim Labs, INC. - 10-Q, Quarterly Report9
29.07.VivoSim Labs, INC. - 10-K/A, Annual Report8
VIVOSIM LABS Aktie jetzt für 0€ handeln
05.06.VivoSim Labs, INC. - 10-K, Annual Report29
06.05.VivoSim Labs, INC. - 8-K, Current Report27
24.04.VivoSim Labs, INC. - 8-K, Current Report20
24.04.VivoSim Labs stellt KI-gestützte Modelle für Medikamententests vor34
24.04.VivoSim Labs introduces AI-driven drug testing models3
24.04.VivoSim Labs, Inc.: VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market628SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company") announced that it has emerged from stealth mode to dramatically impact drug discovery and development....
► Artikel lesen
23.04.Organovo benennt sich in VivoSim Labs um und führt neues Börsenkürzel ein79
23.04.Organovo rebrands as VivoSim Labs, debuts new ticker16
23.04.Organovo, Inc.: VivoSim to Carry Forward Organovo 3D Bioprinting8
23.04.ORGANOVO HOLDINGS, INC. - 8-K, Current Report2
02.04.Organovo, Inc.: Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements433SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches...
► Artikel lesen
27.03.Organovo, Inc.: Organovo Provides Business Update249SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches...
► Artikel lesen
25.03.Organovo Sells FXR Program To Eli Lilly2.374INDIANAPOLIS (dpa-AFX) - Organovo Holdings Tuesday has completed the sale of its FXR program, including lead asset FXR314, to Eli Lilly and Company (LLY).The transaction, finalized on March...
► Artikel lesen
25.03.Organovo, Inc.: Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company590SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches...
► Artikel lesen
Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1